PMID- 35638109 OWN - NLM STAT- MEDLINE DCOM- 20220602 LR - 20220716 IS - 1555-8584 (Electronic) IS - 1547-6286 (Print) IS - 1547-6286 (Linking) VI - 19 IP - 1 DP - 2022 Jan TI - DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m(6)A modification and translation for cytoprotective autophagy in cervical cancer. PG - 751-763 LID - 10.1080/15476286.2022.2079889 [doi] AB - Cervical cancer (CC) is one of the most prevalent malignancies among females. Cytoprotective autophagy could confer cancer cell tolerance to hypoxic stress, promoting cell survival and adaptation. Aspartyl-tRNA synthetase 1 antisense 1 (DARS-AS1) is an oncogenic long non-coding RNA (lncRNA) in various cancers, but how DARS-AS1 regulates cytoprotective autophagy in hypoxic environment in CC remains unclear. Chromatin immunoprecipitation (ChIP) and luciferase reporter assays were conducted to explore the interaction between hypoxia-inducible factor 1 subunit alpha (HIF1alpha) and DARS-AS1 promoter. Methylated RNA immunoprecipitation (MeRIP) followed by quantitative real-time polymerase-chain reaction (RT-qPCR) detected methylated RNA level. The process of autophagic maturation was monitored by immunofluorescence staining. Higher DARS-AS1 expression was found in CC tissues and cytoprotective. We also uncovered that hypoxic exposure induced cytoprotective autophagy via HIF1alpha/DARS-AS1/DARS axis. Moreover, DARS-AS1 was validated to facilitate DARS translation via recruiting N6-adenosine-methyltransferase methyltransferase like 3 (METTL3) and methyltransferase like 14 (METTL14), which bound with DARS mRNA DARS mRNA 5' untranslated region (5'UTR) and promoting its translation. The present study demonstrated that the 'HIF1alpha/DARS-AS1/DARS/ATG5/ATG3' pathway regulated the hypoxia-induced cytoprotective autophagy of CC and might be a promising target of therapeutic strategies for patients afflicted with CC. FAU - Shen, Weiwei AU - Shen W AD - Department of Gynecology, The Affiliated Hospital of Medical School, Ningbo University, Ningbo, Zhejiang, China. FAU - Zhu, Miaohua AU - Zhu M AD - Department of Gynecology, Ningbo Women's & Children's Hospital, Ningbo University, Ningbo, Zhejiang, China. FAU - Wang, Qiming AU - Wang Q AD - Department of Gynecology, Ningbo Women's & Children's Hospital, Ningbo University, Ningbo, Zhejiang, China. FAU - Zhou, Xiaoming AU - Zhou X AD - Department of Gynecology, The Affiliated Hospital of Medical School, Ningbo University, Ningbo, Zhejiang, China. FAU - Wang, Jiaying AU - Wang J AD - Department of Gynecology, The Affiliated Hospital of Medical School, Ningbo University, Ningbo, Zhejiang, China. FAU - Wang, Tingting AU - Wang T AD - Department of Gynecology, The Affiliated Hospital of Medical School, Ningbo University, Ningbo, Zhejiang, China. FAU - Zhang, Jing AU - Zhang J AD - Department of Gynecology, Ningbo Women's & Children's Hospital, Ningbo University, Ningbo, Zhejiang, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - RNA Biol JT - RNA biology JID - 101235328 RN - 0 (RNA, Antisense) RN - 0 (RNA, Messenger) RN - EC 2.1.1.- (METTL14 protein, human) RN - EC 2.1.1.- (Methyltransferases) RN - EC 2.1.1.62 (METTL3 protein, human) SB - IM MH - *Autophagy/genetics MH - Cell Line, Tumor MH - Female MH - Humans MH - *Methyltransferases/genetics MH - RNA, Antisense MH - RNA, Messenger/genetics MH - *Uterine Cervical Neoplasms/genetics PMC - PMC9176263 OTO - NOTNLM OT - DARS-AS1 OT - autophagy OT - cervical cancer OT - m6A modification COIS- No potential conflict of interest was reported by the author(s). EDAT- 2022/06/01 06:00 MHDA- 2022/06/03 06:00 PMCR- 2022/05/30 CRDT- 2022/05/31 14:28 PHST- 2022/05/31 14:28 [entrez] PHST- 2022/06/01 06:00 [pubmed] PHST- 2022/06/03 06:00 [medline] PHST- 2022/05/30 00:00 [pmc-release] AID - 2079889 [pii] AID - 10.1080/15476286.2022.2079889 [doi] PST - ppublish SO - RNA Biol. 2022 Jan;19(1):751-763. doi: 10.1080/15476286.2022.2079889.